19 January 2018 - Deborah Wilkes
Archived
GlaxoSmithKline Consumer Healthcare has struck a deal worth up to USD26.5 million for the Quell wearable pain relief technology from US-based NeuroMetrix.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.